drugset / Trial / NCT06041451
Early and Late Prognosis in Patients With Guillain-Barre Syndrome
RandomizedParallel-groupDouble-blindPrevention
Summary
The goal of this observational study is to explore significant indicators to predict the early prognosis and late prognosis in patients with Guillain-Barre syndrome.
Timeline
- Start
- 2013-01-02
- Primary completion
- 2022-12-01
- Completion
- 2025-01-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Intravenous Immunoglobulins, Human | Protein / enzyme biologic | 30 g | Intravenous |
| Subject | Methylprednisolone | Other / unclassified | 500 mg | — |